Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations
2023; Adis, Springer Healthcare; Volume: 40; Issue: 7 Linguagem: Inglês
10.1007/s12325-023-02523-z
ISSN1865-8652
AutoresRakesh Sahay, Richa Giri, Jayashree Shembalkar, Sandeep K. Gupta, Brij Mohan, Prakash Kurmi, Sravan Kumar, Vinayak Sawardekar, Ashutosh Mishra, L. Sreenivasa Murthy, Vivek V. Arya, Abhijit R. Sonawane, Pravin Soni, Sandip Gofne, S. Karnawat, Mandodari Rajurkar, Piyush M. Patel, Lalit Lakhwani, Suyog C. Mehta, Sadhna J. Joglekar,
Tópico(s)Diabetes Management and Research
Referência(s)